Video

Post-Mastectomy Tattooing: A Personal Decision

For some breast cancer survivors, 3D nipple tattooing is the right choice. Others may turn to body art or choose to do nothing at all.

What breast cancer survivors do after they undergo a mastectomy is a highly personal decision. For Corinne Greiner, a Texas native who has been battling the disease for the past two years, 3D nipple tattooing was the right choice for her.

Greiner underwent a mastectomy, chemotherapy and radiation. Over the summer, she was at a public pool when a child accidentally saw her changing. The girl seemed confused and frightened that Greiner had no nipples, which made the survivor contemplate the options that were best for her.

"It'll help me feel more complete," Greiner said in an interview with CURE at New Jersey's Beau Institute 8th Annual Day of Hope, a day of celebration where breast cancer survivors are offered nipple tattooing free of charge.

Related Videos
Image of woman with black hair.
Image of doctor with brown hair.
Image of man with black hair.
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Related Content
Image of water bottle, weights, and apple.
February 22nd 2025

Debunking the Myth That Healthy People Don’t Get Cancer

Jacey Tramutt Amy Schneidmiller-Johnston
The myth that "healthy people don’t get cancer" contributed to my shame, but I’ve learned that cancer can affect anyone, regardless of lifestyle choices.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
An expert discusses the FDA approval of Enhertu in unresectable or metastatic HR+, HER2-low or -ultralow breast cancer: © stock.adobe.com
February 19th 2025

Understanding the FDA Approval of Enhertu in HER2-Low and -Ultralow Breast Cancer

Ryan Scott
Dr. Debu Tripathy breaks down the FDA approval of Enhertu in unresectable or metastatic HR-positive, HER2-low or -ultralow breast cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Illustration of woman with light brown hair.
February 14th 2025

Are We at Risk of Losing Our Breast Cancer Community?

Martha Carlson
I found community after my metastatic breast cancer diagnosis, but recent discord in cancer support groups makes me fear we're losing these vital connections.
Sue McCarthy received diagnoses of breast cancer in 2001 and lung cancer in 2018. Catch up on all of Sue's blogs here!
February 13th 2025

Facing Cancer Together: Jim and Melanie’s Patient-Caregiver Story

Sue McCarthy
Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's sarcoma diagnosis.